An internal working group of the US Food and Drug Administration has proposed over 70 changes to the pre-market notification or 510(k) process for clearing medical devices1. Taken together, the medtech industry fears that the proposals could result in a "significant disruption" to the programme that it says has served the patients well since the system was established in 19762...
Please login to read the full article.
